| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $471.9M | +31.3% |
| R&D Expense | $111.1M | +68.4% |
| SG&A Expense | $100.8M | +76.0% |
| Operating Income | -$72.4M | -509.3% |
| Pre-tax Income | -$66.7M | -3947.6% |
| Income Tax | $1.4M | +98.6% |
| Net Income | -$68.1M | -6726.4% |
| EPS (Basic) | -$1.95 | -6600.0% |
| EPS (Diluted) | -$1.95 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.8M | +22.3% |
| Accounts Receivable | $16.5M | +31.0% |
| Current Assets | $201.5M | +27.0% |
| Total Assets | $381.2M | -6.6% |
| Current Liabilities | $61.3M | +16.5% |
| Total Liabilities | $115.7M | +4.6% |
| Stockholders' Equity | $265.5M | -10.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.4M | -28.3% |
| Capital Expenditures | $6.5M | -19.3% |
| Investing Cash Flow | -$6.5M | +94.1% |
| Financing Cash Flow | -$6.2M | +16.1% |
| Free Cash Flow | $18.8M | -31.0% |
| -6600.0% |